Pharmaron Beijing Co., Ltd. (HKG:3759)
Hong Kong · Delayed Price · Currency is HKD 21.66
-0.02 (-0.09%)
Dec 5, 2025, 4:09 PM HKT
Pharmaron Beijing Market Cap
Pharmaron Beijing has a market cap or net worth of 53.87 billion as of December 5, 2025. Its market cap has decreased by -2.15% in one year.
Market Cap
53.87B
Enterprise Value
59.02B
Revenue
14.80B
Ranking
n/a
PE Ratio
32.59
Stock Price
21.66
Market Cap Chart
Since January 28, 2019, Pharmaron Beijing's market cap has increased from 8.42B to 53.87B, an increase of 539.65%. That is a compound annual growth rate of 31.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 53.87B | 20.97% |
| Dec 31, 2024 | 44.53B | -14.67% |
| Dec 29, 2023 | 52.19B | -40.01% |
| Dec 30, 2022 | 86.99B | -33.39% |
| Dec 31, 2021 | 130.60B | 16.63% |
| Dec 31, 2020 | 111.98B | 155.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 285.39B |
| Hansoh Pharmaceutical Group Company | 253.90B |
| JD Health International | 192.57B |
| Innovent Biologics | 160.32B |
| WuXi Biologics | 134.32B |
| Sino Biopharmaceutical | 122.99B |
| Akeso | 114.31B |
| Sichuan Kelun-Biotech Biopharmaceutical | 104.70B |